NCT03295747View on ClinicalTrials.gov

Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 15, 2017

Primary Completion Date

March 28, 2019

Study Completion Date

March 28, 2019

Conditions
Abdominal Pain
Interventions
DRUG

Peppermint oil

Three doses of peppermint oil will be investigated: 180, 360, 540 mg; i.e. three arms.

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Robert Shulman, M.D.

OTHER

NCT03295747 - Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain | Biotech Hunter | Biotech Hunter